EU Approves P&G Takeover of Teva Drugs Division

Oct. 2, 2011
In March the companies announced the acquisition covering pain-relief and other products with sales of around a billion dollars.

The European Commission gave its green light on Sept. 30 to the takeover by Procter & Gamble of the 'over-the-counter' division of Israeli drugmaker Teva.

Anti-trust inspectors "concluded that the proposed transaction would not raise competition concerns, because the merged entity would continue to face sufficient competition in the markets concerned," Brussels said.

The companies announced in March the tie-up covering pain-relief and other products with sales of around a billion dollars.

Copyright Agence France-Presse, 2011

Popular Sponsored Recommendations

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

Powering Up Productivity: The Transformative Power of AP Automation in Manufacturing

Oct. 25, 2023
Discover how AP Automation is revolutionizing the manufacturing industry, driving efficiency, cost savings, and security. In today's world, automation is the key to staying competitive...

Discrete and Process Manufacturing 2024 Trends and Outlook for North America

Oct. 29, 2023
Manufacturers are reaping the benefits of automation and cloud-based solutions. Discover what is driving today's industry trends and how they can shape your growth priorities ...

The Benefits of Continuous Thermal Monitoring

Oct. 17, 2023
Read this eBook to learn more about collecting and using data intelligently to improve performance.

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!